XERO FPO's new CEO: Is it still a buy?

With a new CEO to replace founder Rod Drury, is XERO FPO (ASX:XRO) still an opportunity?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Cloud accounting software company XERO FPO (ASX: XRO) recently wrote to shareholders about the departure of founder and CEO Rod Drury, and his replacement, Steve Vamos. The departure of a founder is always a concern for an investor, especially if the founder has represented their company as well as I feel that Rod Drury represented Xero.

Mr Drury steps back from the CEO role at the end of this month and will become a non-executive director, with Steve Vamos taking over from April 1.

According to his LinkedIn, Mr Vamos has worked in major companies such as IBM (1979-1994), Apple Computer ANZ/Asia Pacific (1995-1998) and then in various roles at Microsoft including CEO of Microsoft Australia and VP of Worldwide Sales.

He's also been a non-executive director at a number of companies including Medibank Private Ltd (ASX: MPL) and Telstra Corporation Ltd (ASX: TLS). He is very experienced and, reading between the lines, it looks as though running Xero will increasingly be about running a large corporation rather than designing new products, which is why Rod Drury is stepping down.

The question for shareholders is, what's likely to change?

I think the answer is not much. At this stage, Xero appears to be running like a well-oiled machine and I think much of its future success will come from repeating a well-established process – developing new features and rolling out its product in new markets. The company should be able to fund itself from here, and Mr Vamos' expertise with global sales at Microsoft will likely come in handy.

Should it go badly for some reason, as a director Mr Drury will be in a position to vote on the CEO, and, as a ~13% shareholder, will likely still exercise significant influence over the company.

As a result I think the company is in safe hands and I remain a happy Xero shareholder.

Motley Fool contributor Sean O'Neill owns shares of Xero. The Motley Fool Australia owns shares of and has recommended Telstra Limited. The Motley Fool Australia owns shares of Xero. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »